News & Analysis on Clinical Trial Services & Contract Research And Development
The rise of the biotechnology industry is set to create additional pressure on pharmaceutical companies, who already have to deal with unreasonable expectations, where even common molecule failure in the R&D stages result in loss of investor...
Corgentech announced that its drug candidate was effective in preclinical studies in reducing disease activity in models of Crohn's disease and ulcerative colitis-both also referred to as inflammatory bowel disease (IBD), which affects up to over two...
French public prosecutors have expanded their criminal investigations into alleged accounting irregularities by specialty chemicals maker Rhodia, with a raid on the country's Ministry of Finance.
Scientists in the drug discovery arena, who need to assess cellular function, in particular, mitochondrial membrane potential, cellular proliferation and activation of caspase 3/7 or 8 enzymes, are set to benefit from Guava Technology's assays for its...
German pharmaceutical firm, Schering took the opportunity, during the company’s annual financial meeting, to provide an update on its drug development pipeline, which concentrates on the disease areas of hormonal therapies, cancer drugs, imaging...
Scientists at the University of North Carolina at Chapel Hill, US, have developed a method of creating what they claim are the world's smallest manufactured particles for delivering drugs and other organic materials into the human body.
Another week, another Indian acquisition of a European or US pharmaceutical company. In the latest case, Torrent Pharmaceuticals has agreed to acquire Heumann Pharma Generics of Germany through its wholly owned German affiliate, Torrent Pharma GmbH.